ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Aligos Therapeutics Inc

Aligos Therapeutics Inc (ALGS)

25.78
-0.97
(-3.63%)
Closed December 04 4:00PM
26.00
0.22
(0.85%)
After Hours: 6:56PM

Aligos Therapeutics Inc Financial Summary

The current ALGS market cap is 93.29M. The company's latest EPS is USD -24.4375 and P/E is -1.06.

Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 2.72M6.89M3.24M2.68M986k
Operating Income -23.92M-19.14M-18.21M-26M-22.05M
Net Income -22.96M-18.72M-18.11M-27.89M-34.86M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 004.36M13.91M15.53M
Operating Income -54.04M-97.83M-128.32M-97.58M-88.13M
Net Income -52.26M-108.54M-128.33M-96.05M-87.68M
Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 121.74M106.13M85.85M151.53M127.9M
Total Liabilities 36.99M36.5M31.03M59.45M68.11M
Total Equity 84.75M69.64M54.82M92.08M59.8M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 146.52M265.3M235.37M146.69M151.53M
Total Liabilities 29.33M45.26M50.64M42.79M59.45M
Total Equity -64.89M220.04M184.73M103.9M92.08M
Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -22.39M-36M-56.34M-79M-22.75M
Investing 19.99M45M44.99M44.98M-88.64M
Financing -1,000413k392k88.33M-19k
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -46.77M-74.26M-115.66M-79.39M-79M
Investing 6.79M32.76M3.02M-26.29M44.98M
Financing 85.53M192.35M78.68M164k88.33M
Market Cap 93.29M
Price to Earnings Ratio -1.06
Price to Sales Ratio 5.97
Price to Cash Ratio 0.68
Price to Book Ratio 1.01
Dividend Yield -

Share Statistics

Shares Outstanding 3.59M
Average Volume (1 week) 399.87k
Average Volume (1 Month) 680.73k
52 Week Change 48.57%
52 Week High 30.00
52 Week Low 6.76
Spread (Intraday) 0.77 (2.88%)

Company Info

Company Name Aligos Therapeutics Inc
Address 1209 orange street
wilmington, delaware 19801
Website https://www.aligos.com
Industry biological pds,ex diagnstics (2836)

Your Recent History

Delayed Upgrade Clock